Perrier, Q., Noble, J., Grangé, S., Bedouch, P., Tetaz, R., & Rostaing, L. (2021). Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies. Case Rep Oncol.

Perrier, Quentin, Johan Noble, Steven Grangé, Pierrick Bedouch, Rachel Tetaz, and Lionel Rostaing. "Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined As Paraneoplastic Syndrome Under Eculizumab and Palbociclib Therapies." Case Rep Oncol 2021.

Perrier, Quentin, et al. "Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined As Paraneoplastic Syndrome Under Eculizumab and Palbociclib Therapies." Case Rep Oncol 2021.